Matt Abernethy, Chief Financial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,514 shares at $90.74 ($410K) on 2020-11-12, disclosed to the SEC on 2020-11-16.
Open-market sale of $410k NBIX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.74 | 2,257 | $205K | 50.0% |
| 2 | $90.74 | 2,257 | $205K | 50.0% |
| Total | $90.74 avg | 4,514 | $410K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $392K | — | Filing → |
| NBIX | SELL | 2024-08-15 | $2.1M | — | Filing → |